Department of Radiology, University of Texas Southwestern Medical Center at Dallas and Children's Medical Center, 1935 Medical District Drive, Dallas, TX 75235, USA.
Acad Radiol. 2012 Jan;19(1):35-9. doi: 10.1016/j.acra.2011.08.018. Epub 2011 Nov 3.
Medulloblastoma/primitive neuroectodermal tumor (MB/PNET) is the most common malignant tumor of the central nervous system (CNS) in children. MB/PNET survivors are at an increased risk for developing second malignancies. Little has been reported on development of low-grade lesions of the calvarium in the radiation field in MB/PNET survivors. The purpose of this study was to assess the frequency of the low-grade bone lesion development in the radiotherapy field in pediatric MB/PNET survivors and describe the imaging characteristics of these lesions.
Institutional review board approval was obtained for this retrospective review which was compliant with Health Insurance Portability and Accountability Act. Forty-one MB/PNET patients (29 male) who survived for at least 2 years after initiation of radiation therapy were included. The medical records were reviewed. The most recent available brain magnetic resonance imaging studies were evaluated.
Three patients (7.3%) developed low-grade calvarial lesions and underwent resection and/or biopsy of the lesions. There were one Langerhans cell histiocytosis, one benign spindle cell lesion with myxoid change, and one fibrous dysplasia.
Development of low-grade bone lesions of calvarium is not very rare in pediatric PNET/MB survivors. Bones in the radiation therapy field need to be carefully examined for assessment of secondary lesions.
成神经管细胞瘤/原始神经外胚层肿瘤(MB/PNET)是儿童中枢神经系统(CNS)最常见的恶性肿瘤。MB/PNET 幸存者发生第二恶性肿瘤的风险增加。关于 MB/PNET 幸存者在放射治疗场中颅盖骨低级病变的发展,报道甚少。本研究的目的是评估小儿 MB/PNET 幸存者在放射治疗场中低级骨病变发展的频率,并描述这些病变的影像学特征。
本回顾性研究获得了机构审查委员会的批准,符合《健康保险携带和责任法案》。共纳入 41 例 MB/PNET 患者(29 例男性),这些患者在开始放射治疗后至少存活 2 年。回顾了病历。评估了最近可获得的脑磁共振成像研究。
3 名患者(7.3%)出现低级颅骨病变,并对病变进行了切除和/或活检。其中包括 1 例朗格汉斯细胞组织细胞增生症、1 例良性梭形细胞病变伴黏液样变和 1 例纤维结构不良。
在小儿 PNET/MB 幸存者中,颅盖骨低级骨病变的发展并不罕见。需要仔细检查放射治疗场中的骨骼以评估继发性病变。